EU TRANSPARENCY REGISTER · 180203343227-11 · Belgium

ExeVir Bio

ExeVir

Category

Companies & groups

Country

Belgium

Ghent

Entity form

Besloten vennootschap

Stated objectives

ExeVir is a clinical-stage company developing novel antibody therapies that help patients ward off infectious diseases. Our focus is to protect populations unable to benefit from vaccines, such as immunocompromised individuals. The versatil…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2021-06-18

Last updated

2025-08-19

Other Companies & groups in Belgium

Other registered organisations in Belgium

Frequently asked questions

What is this organisation?
ExeVir Bio (ExeVir) is an interest representative listed in the EU Joint Transparency Register under ID 180203343227-11. Entity form: Besloten vennootschap.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in Belgium, Ghent.
What are its stated goals?
As declared by the registrant: ExeVir is a clinical-stage company developing novel antibody therapies that help patients ward off infectious diseases. Our focus is to protect populations unable to benefit from vaccines, such as immunocompromised individuals. The versatil…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 180203343227-11.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-05 · Commission Reuse Decision 2011/833/EU